Moxilubant (hydrochloride)
Moxilubant hydrochloride (CGS-25019C hydrochloride) is an orally active BLT1 antagonist which inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant hydrochloride can be used for cancer research[1].
Product Specifications
CAS Number
146957-32-6
Product Name Alternative
CGS 25019C (hydrochloride)
UNSPSC
12352005
Target
Leukotriene Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/moxilubant-hydrochloride.html
Smiles
[H]Cl.CC(C)N(C(C)C)C(C1=CC(OC)=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)=O
Molecular Formula
C26H38ClN3O4
Molecular Weight
492.05
References & Citations
[1]Bhatt L, et al. Recent advances in clinical development of leukotriene B4 pathway drugs. Semin Immunol. 2017 Oct;33:65-73.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402298-100 1x 100 µL
Cytokeratin 8/18 (rKRT8.18/1346), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-B190025-1MG 1 mg
1,2,4-Benzenetricarboxylic Acid 1-(2-ethylhexyl) Ester
Sign In for Pricing
View Details 
